Search
Monopar Therapeutics Inc
MNPRAdd to Watchlist
72.000USD
-0.680-0.94%
Close 11-13 16:00（ET）
483.12MMarket Cap
LossP/E TTM
After-hours 19:06 (ET)72.000USD+0.375+0.52%
After-hours 19:06 (ET)Today
-0.94%
5 Days
+0.81%
1 Month
-1.50%
6 Months
+18.05%
Year to Date
+10.26%
1 Year
-7.69%
Key Figures
72.930Open
75.032High
5.90KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.09%Turnover Ratio
72.680Prev. Close
67.120Low
419.45KTurnover
LossP/E Static
3.69P/B
0.00%Div Yield TTM
-15.52%ROA
124.82052wk High
0.05Volume Ratio
-15.59MNet Profit
6.71MShares
-1.9313EPS TTM
1.53Beta
-15.86%ROE
50.07052wk Low
10.89%Amplitude
--Gross Margin
483.12MMarket Cap
1.50Reward/Risk
4.02%Risk Rate
More news coming soon, stay tuned...
Monopar Therapeutics Inc's Score
0.00vs previous score
Forecast8.15
Financial Health7.37
Technical4.43
Valuation Dimensions9.36
Institutional Confidence7.00
Risk Assessment--
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Monopar Therapeutics Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.72/-0.87
Revenue / Forecast
--/0.00
Monopar Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolMNPR
Number of employees16
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Janus Henderson Investors | 19.67% |
| RA Capital Management, LP | 9.96% |
| Adage Capital Management, L.P. | 9.55% |
| Gem Pharmaceuticals LLC | 8.47% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor/Hedge Fund | 31.16% |
| Hedge Fund | 24.54% |
| Corporation | 16.28% |
| Investment Advisor | 15.55% |
Related Instruments
+1.26%
+0.79%
+0.20%
+0.55%
+0.16%
+0.04%
-0.30%
+0.08%
+2.41%
+0.21%
-0.74%
+1.78%
+2.39%
-0.19%
+0.52%
+0.45%
-3.45%
+1.47%
+1.06%
-2.17%
FAQs
What is the current price of Monopar Therapeutics Inc (MNPR)?
The current price of Monopar Therapeutics Inc (MNPR) is 72.00.
What is the symbol of Monopar Therapeutics Inc?
The ticker symbol of Monopar Therapeutics Inc is MNPR.
What is the 52-week high of Monopar Therapeutics Inc?
The 52-week high of Monopar Therapeutics Inc is 124.82.
What is the 52-week low of Monopar Therapeutics Inc?
The 52-week low of Monopar Therapeutics Inc is 50.07.
What is the market capitalization of Monopar Therapeutics Inc?
The market capitalization of Monopar Therapeutics Inc is 483.12M.
Is Monopar Therapeutics Inc (MNPR) currently rated as Buy, Hold, or Sell?
According to analysts, Monopar Therapeutics Inc (MNPR) has an overall rating of Buy, with a price target of 127.42.
What is the Earnings Per Share (EPS TTM) of Monopar Therapeutics Inc (MNPR)?
The Earnings Per Share (EPS TTM) of Monopar Therapeutics Inc (MNPR) is -1.93.